tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alterity Therapeutics Reports Promising Phase 2 Results for MSA Treatment
PremiumCompany AnnouncementsAlterity Therapeutics Reports Promising Phase 2 Results for MSA Treatment
5d ago
Alterity Therapeutics announces publication on MRI endpoint from bioMUSE study
Premium
The Fly
Alterity Therapeutics announces publication on MRI endpoint from bioMUSE study
8d ago
Alterity Therapeutics Unveils New MRI Endpoint for MSA Diagnosis and Progression
Premium
Company Announcements
Alterity Therapeutics Unveils New MRI Endpoint for MSA Diagnosis and Progression
9d ago
Alterity Therapeutics to Update on ATH434 Progress in Upcoming Fireside Chat
PremiumCompany AnnouncementsAlterity Therapeutics to Update on ATH434 Progress in Upcoming Fireside Chat
1M ago
BNY Mellon Increases Stake in Alterity Therapeutics
Premium
Company Announcements
BNY Mellon Increases Stake in Alterity Therapeutics
2M ago
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
Premium
The Fly
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
3M ago
Alterity Therapeutics management to meet with Maxim
PremiumThe FlyAlterity Therapeutics management to meet with Maxim
3M ago
Alterity Therapeutics to Showcase MSA Research at 2025 Congress
Premium
Company Announcements
Alterity Therapeutics to Showcase MSA Research at 2025 Congress
3M ago
Alterity Therapeutics granted U.S. FDA Fast Track designation for ATH434
Premium
The Fly
Alterity Therapeutics granted U.S. FDA Fast Track designation for ATH434
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100